175 related articles for article (PubMed ID: 35344084)
1. Diagnostic and prognostic value of Bcl-2 in uterine leiomyosarcoma.
Travaglino A; Raffone A; Raimondo D; Gencarelli A; Esposito I; Gallo C; Improda FP; Vitale SG; Mollo A; Casadio P; Seracchioli R; Zullo F; Insabato L
Arch Gynecol Obstet; 2023 Feb; 307(2):379-386. PubMed ID: 35344084
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
3. Roles of Matrix Metalloproteinases 2 and 9 in Uterine Leiomyosarcoma.
Wang X; Li C; Lou L; Zhu H
Anticancer Res; 2024 Apr; 44(4):1465-1473. PubMed ID: 38537953
[TBL] [Abstract][Full Text] [Related]
4. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.
Oduyebo T; Rauh-Hain AJ; Meserve EE; Seidman MA; Hinchcliff E; George S; Quade B; Nucci MR; Del Carmen MG; Muto MG
Gynecol Oncol; 2014 Feb; 132(2):360-5. PubMed ID: 24296345
[TBL] [Abstract][Full Text] [Related]
5. Ki67 as a prognostic marker in uterine leiomyosarcoma: A quantitative systematic review.
Travaglino A; Raffone A; Catena U; De Luca M; Toscano P; Del Prete E; Vecchione ML; Lionetti R; Zullo F; Insabato L
Eur J Obstet Gynecol Reprod Biol; 2021 Nov; 266():119-124. PubMed ID: 34624740
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical panel to differentiate endometrial stromal sarcoma, uterine leiomyosarcoma and leiomyoma: something old and something new.
Hwang H; Matsuo K; Duncan K; Pakzamir E; Pham HQ; Correa A; Fedenko A; Mhawech-Fauceglia P
J Clin Pathol; 2015 Sep; 68(9):710-7. PubMed ID: 25991737
[TBL] [Abstract][Full Text] [Related]
7. p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas.
Anderson SE; Nonaka D; Chuai S; Olshen AB; Chi D; Sabbatini P; Soslow RA
Int J Gynecol Cancer; 2006; 16(2):849-53. PubMed ID: 16681772
[TBL] [Abstract][Full Text] [Related]
8. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma.
George S; Barysauskas C; Serrano C; Oduyebo T; Rauh-Hain JA; Del Carmen MG; Demetri GD; Muto MG
Cancer; 2014 Oct; 120(20):3154-8. PubMed ID: 24923260
[TBL] [Abstract][Full Text] [Related]
9. Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid.
Zhang G; Yu X; Zhu L; Fan Q; Shi H; Lang J
BMC Cancer; 2020 Jun; 20(1):514. PubMed ID: 32493236
[TBL] [Abstract][Full Text] [Related]
10. The selected biomarker analysis in 5 types of uterine smooth muscle tumors.
Zhang Q; Kanis MJ; Ubago J; Liu D; Scholtens DM; Strohl AE; Lurain JR; Shahabi S; Kong B; Wei JJ
Hum Pathol; 2018 Jun; 76():17-27. PubMed ID: 29258902
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma.
Schwameis R; Grimm C; Petru E; Natter C; Staudigl C; Lamm W; Koelbl H; Krainer M; Brodowicz T; Reinthaller A; Polterauer S
PLoS One; 2015; 10(8):e0133838. PubMed ID: 26248232
[TBL] [Abstract][Full Text] [Related]
12. CD147 expression in uterine smooth muscle tumors, and its potential role as a diagnostic and prognostic marker in patients with leiomyosarcoma.
Ozler A; Evsen MS; Turgut A; Sak ME; Tunc SY; Agacayak E; Alabalik U; Basaranoglu S; Keles AN; Gul T
J Exp Ther Oncol; 2014; 10(4):325-30. PubMed ID: 25509988
[TBL] [Abstract][Full Text] [Related]
13. [The differential diagnosis between uterine leiomyosarcoma and the special subtypes of leiomyoma].
Zhu XQ; Shi YF; Cheng XD; Wu YZ
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(16):1419-21. PubMed ID: 14521746
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation with overexpression of the mTORC2-phospholipase D1 pathway in uterine leiomyosarcoma and STUMP: morphoproteomic analysis with therapeutic implications.
Dhingra S; Rodriguez ME; Shen Q; Duan X; Stanton ML; Chen L; Zhang R; Brown RE
Int J Clin Exp Pathol; 2010 Jan; 4(2):134-46. PubMed ID: 21326806
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner-Adler B; Bodner K; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):182-6. PubMed ID: 15051038
[TBL] [Abstract][Full Text] [Related]
17. The Role of Endometrial Biopsy in the Preoperative Detection of Uterine Leiomyosarcoma.
Hinchcliff EM; Esselen KM; Watkins JC; Oduyebo T; Rauh-Hain JA; Del Carmen MG; Quade BJ; Muto MG
J Minim Invasive Gynecol; 2016; 23(4):567-72. PubMed ID: 26851414
[TBL] [Abstract][Full Text] [Related]
18. DNA fragmentation factors 40 and 45 (DFF40/DFF45) and B-cell lymphoma 2 (Bcl-2) protein are underexpressed in uterine leiomyosarcomas and may predict survival.
Banas T; Pitynski K; Okon K; Czerw A
Onco Targets Ther; 2017; 10():4579-4589. PubMed ID: 29075126
[TBL] [Abstract][Full Text] [Related]
19. [The loss of heterozygosity and microsatellite instability analysis in differential diagnostics of leiomyosarcoma and proliferative leiomyoma of the uterus].
Shikeeva AA; Kekeeva TV; Zavalishina LÉ; Andreeva IuIu; Frank GA
Arkh Patol; 2011; 73(4):47-50. PubMed ID: 22164433
[TBL] [Abstract][Full Text] [Related]
20. Gamma Secretase Inhibitors as Potential Therapeutic Targets for Notch Signaling in Uterine Leiomyosarcoma.
Abedin Y; Gabrilovich S; Alpert E; Rego E; Begum S; Zhao Q; Heller D; Einstein MH; Douglas NC
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
